25 results
DEFM14A
AMTI
Applied Molecular Transport Inc.
21 Nov 23
Proxy related to merger
9:16am
of substantial value;
enter into any contract, understanding or commitment that contains any restrictive covenant or otherwise materially restrains, restricts … proposal or commitment to a development partner regarding the adoption, approval, modification or amendment of any such plan or program, (ii) initiate
425
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Business combination disclosure
5:12pm
is not a party to, and has no commitment to become a party to: (i) any joint venture, off-balance sheet partnership, or any similar Contract … as a result of or pursuant to any such agreement, contract, arrangement or commitment, other than in each case, an agreement, contract, arrangement
8-K
EX-99.1
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
to demonstrate its commitment to developing life-changing medicines and execution across clinical and regulatory fronts. Our board and management believe
8-K
EX-2.1
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
to the satisfaction of the Company’s auditors.
(h) The Company is not a party to, and has no commitment to become a party to: (i) any joint venture … the Company have a potential liability or obligation to any person as a result of or pursuant to any such agreement, contract, arrangement or commitment, other
8-K
EX-10.1
1eynsqrr
4 Mar 22
Departure of Directors or Certain Officers
6:06am
8-K
EX-10.1
v9qwfxpk tx3r5
27 Jan 22
Applied Molecular Transport Announces Board Appointments
5:09pm
8-K
EX-99.1
1b06iqsf45uw
10 Nov 21
Applied Molecular Transport Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:11pm
424B4
ikequl2z4mory
1 Apr 21
Prospectus supplement with pricing info
4:05pm
10-K
4wq8qnl6 jfg
19 Mar 21
Annual report
4:11pm
DRS
839rn
19 Mar 21
Draft registration statement
12:00am
424B4
x328kf71a u2i0uiwf
5 Jun 20
Prospectus supplement with pricing info
4:52pm
S-1
tyqhm ne6tcodg
18 May 20
IPO registration
4:03pm
S-1
EX-3.1
wivjkc 72rywf20setw
18 May 20
IPO registration
4:03pm